Literature DB >> 810021

Infections in cancer patients on a protected environment-prophylactic antibiotic program.

G P Bodey, V Rodriguez.   

Abstract

A total of 102 studies were conducted on 89 patients receiving cancer chemotherapy while on a protected environment-prophylactic antibiotic program. Major infections occurred during 22 studies. The majority of both minor and major infections originated during the first five weeks after the patients entered the protected environment units. The frequency of infectious complications was inversely related to the circulating neutrophil count. The majority of infections were cases of cellulitis, pharyngitis, pneumonia and septicemia. Most of the infections were caused by gram-negative bacilli. The majority of organisms causing infection had persisted in the patients after their entry into the protected environment units despite the use of prophylactic antibiotics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810021     DOI: 10.1016/0002-9343(75)90257-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Comparison between two non-absorbable antibiotic regimens for decontamination of the oropharynx.

Authors:  L Borthen; A Heimdahl; C E Nord
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

2.  Evaluation of the AutoMicrobic system for identification of yeasts.

Authors:  J J Hasyn; H R Buckley
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

3.  Preventing infection in neutropenic cancer patients.

Authors:  S M Beutler; N M Barth; A S Bayer
Journal:  West J Med       Date:  1983-05

4.  Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses.

Authors:  W Hofstra; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Collaborative evaluation of the Abbott yeast identification system.

Authors:  B H Cooper; S Prowant; B Alexander; D H Brunson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

6.  Rapid identification of yeasts by semi-automated and conventional methods.

Authors:  S M Qadri; D J Flournoy; S G Qadri; E G Ramirez
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

Review 7.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Septicemia in children with leukemia.

Authors:  Y DeClerck; D DeClerck; G E Rivard; P Benoit
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

9.  Isolation and rapid identification of yeasts from compromised hosts.

Authors:  G A Land; G L Dorn; W H Fleming; T A Beadles; J H Foxworth
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

10.  Susceptibility of clinical isolates of yeasts to anti-fungal agents.

Authors:  S M Hussain Qadri; D J Flournoy; S G Qadri; E G Ramirez
Journal:  Mycopathologia       Date:  1986-09       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.